Remove 2025 Remove Clinic Remove Nuclear Medicine
article thumbnail

Imaging societies' reactions mixed on finalized MPFS, HOPPS rules

AuntMinnie

Centers for Medicare & Medicaid Services (CMS) 2025 Medicare Physician Fee Schedule (MPFS) and Hospital Outpatient Prospective Payment System (HOPPS) final rules. Although the 2025 MPFS calls for an overall 2.9% The change to the MPFS conversion factor reflects the 0% update required by statute for 2025, the expiration of the 2.9%

article thumbnail

New guidelines cover theranostics for brain tumors

AuntMinnie

The article was published October 10 in the Journal of Nuclear Medicine. Overall, these developments have led to an increase in the use of SSTR-directed PET imaging and therapy in routine clinical practice and its integration into clinical trials,” the authors wrote.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

ARRS awards scholarships to two emerging researchers

AuntMinnie

The American Roentgen Ray Society (ARRS) is awarding its two 2024 ARRS Scholarships to Ian Mark, MD, of Mayo Clinic Minnesota and Evan Calabrese, MD, PhD, of Duke University Medical Center. Mark completed his diagnostic radiology residency at Mayo Clinic, where he was chief resident. Ian Mark, MD. Image courtesy of the ARRS.

article thumbnail

Blue Earth Therapeutics Reports Promising Phase 1 Data for Investigational Therapies

Imaging Technology

Based on the advantageous results for absolute tumor and normal organ uptake seen in Phase 1, the Phase 2 study will explore the following concepts: Administration of a significantly higher overall injected radioactivity in comparison to recent Phase 3 clinical trials of other agents. Journal of Nuclear Medicine (2024).

article thumbnail

NorthStar Medical Radioisotopes and Curadh MTR Enter Strategic Collaboration Agreement for Development and Production of Actinium-225 (Ac-225)-based Therapeutic Radiopharmaceuticals for Treatment of Primary and Metastatic Solid Tumors

Imaging Technology

Curadh), a global MTR-focused clinical, research and advisory organization, today announced a long-term strategic collaboration to develop and produce novel radiopharmaceuticals for the diagnosis and treatment of solid tumor cancers.

article thumbnail

Meet the Minnies 2024 semifinal candidates

AuntMinnie

Assessment of Claimant, Clinical, and Financial Characteristics of Teleradiology Medical Malpractice Cases. Luthria, et al, Journal of Nuclear Medicine , October 26, 2023. Neuroimaging and Clinical Findings in Healthy Middle-Aged Adults With Mild Traumatic Brain Injury in the PREVENT Dementia Study.

article thumbnail

NorthStar Medical Radioisotopes Provides Updates on Corporate Progress and Upcoming Milestones

Imaging Technology

Mr. Merrick concluded, “This is a very exciting and dynamic time for NorthStar and all those involved in nuclear medicine. Ac-225 supply to advance clinical research and ensure adequate availability for commercial radiopharmaceutical products. Ac-225 radioisotopes is non-uranium based and highly efficient. NorthStar has n.c.a.

Medical 98